|
1
|
Raimondi S, Suppa M and Gandini S:
Melanoma epidemiology and sun exposure. Acta Derm Venereol.
100:adv001362020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Waseh S and Lee JB: Advances in melanoma:
Epidemiology, diagnosis, and prognosis. Front Med (Lausanne).
10:12684792023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eisemann N, Schumann L, Baltus H, Labohm
L, Kraywinkel K and Katalinic A: Longer survival from melanoma in
Germany. Dtsch Arztebl Int. 121:45–51. 2024.PubMed/NCBI
|
|
4
|
Toussi A, Mans N, Welborn J and Kiuru M:
Germline mutations predisposing to melanoma. J Cutan Pathol.
47:606–616. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holly EA, Kelly JW, Shpall SN and Chiu SH:
Number of melanocytic nevi as a major risk factor for malignant
melanoma. J Am Acad Dermatol. 17:459–468. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fears TR, Scotto J and Schneiderman MA:
Mathematical models of age and ultraviolet effects on the incidence
of skin cancer among whites in the United States. Am J Epidemiol.
105:420–427. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen S, Chen Y, Liu X, Li M, Wu B, Li Y,
Liang Y, Shao X, Holthöfer H and Zou H: Insulin resistance and
metabolic syndrome in normal-weight individuals. Endocrine.
46:496–504. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fracanzani AL, Valenti L, Bugianesi E,
Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D,
Marchesini G and Fargion S: Risk of severe liver disease in
nonalcoholic fatty liver disease with normal aminotransferase
levels: A role for insulin resistance and diabetes. Hepatology.
48:792–798. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Czech MP: Mechanisms of insulin resistance
related to white, beige, and brown adipocytes. Mol Metab. 34:27–42.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan X, Gao Y, Tong J, Tian M, Dai J and
Zhuang Y: Association between triglyceride glucose index and
non-small cell lung cancer risk in Chinese population. Front Oncol.
11:5853882021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Panigoro SS, Sutandyo N, Witjaksono F,
Siregar NC, Ramli R, Hariani R, Pangarsa EA, Prajoko YW, Puruhita
N, Hamdani W, et al: The association between triglyceride-glucose
index as a marker of insulin resistance and the risk of breast
cancer. Front Endocrinol (Lausanne). 12:7452362021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alkurt EG, Şahin F, Tutan B, Canal K and
Turhan VB: The relationship between papillary thyroid cancer and
triglyceride/glucose index, which is an indicator of insulin
resistance. Eur Rev Med Pharmacol Sci. 26:6114–6120.
2022.PubMed/NCBI
|
|
13
|
Li W, Liu T, Qian L, Wang Y, Ma X, Cao L,
Zhang Q and Qu J: Insulin resistance and inflammation mediate the
association of abdominal obesity with colorectal cancer risk. Front
Endocrinol (Lausanne). 13:9831602022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
DeFronzo RA, Tobin JD and Andres R:
Glucose clamp technique: A method for quantifying insulin secretion
and resistance. Am J Physiol. 237:E214–E223. 1979.PubMed/NCBI
|
|
15
|
Sánchez-García A, Rodríguez-Gutiérrez R,
Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A,
Solis RC, Álvarez-Villalobos NA and González-González JG:
Diagnostic accuracy of the triglyceride and glucose index for
insulin resistance: A systematic review. Int J Endocrinol.
2020:46785262020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rohm TV, Meier DT, Olefsky JM and Donath
MY: Inflammation in obesity, diabetes, and related disorders.
Immunity. 55:31–55. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim DS and Scherer PE: Obesity, diabetes,
and increased cancer progression. Diabetes Metab J. 45:799–812.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Poznyak A, Grechko AV, Poggio P,
Myasoedova VA, Alfieri V and Orekhov AN: The diabetes
mellitus-atherosclerosis connection: The role of lipid and glucose
metabolism and chronic inflammation. Int J Mol Sci. 21:18352020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gado M, Tsaousidou E, Bornstein SR and
Perakakis N: Sex-based differences in insulin resistance. J
Endocrinol. 261:e2302452024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bagnardi V, Rota M, Botteri E, Tramacere
I, Islami F, Fedirko V, Scotti L, Jenab M, Turati F, Pasquali E, et
al: Alcohol consumption and site-specific cancer risk: A
comprehensive dose-response meta-analysis. Br J Cancer.
112:580–593. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saladi RN, Nektalova T and Fox JL:
Induction of skin carcinogenicity by alcohol and ultraviolet light.
Clin Exp Dermatol. 35:7–11. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu J, Liu W, Liu X, Zhou X and Li G:
Alcohol drinking, smoking, and cutaneous melanoma risk: Mendelian
randomization analysis. Gac Sanit. 37:1023512023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gandini S, Masala G, Palli D, Cavicchi B,
Saieva C, Ermini I, Baldini F, Gnagnarella P and Caini S: Alcohol,
alcoholic beverages, and melanoma risk: A systematic literature
review and dose-response meta-analysis. Eur J Nutr. 57:2323–2332.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reaven GM: Banting lecture 1988. Role of
insulin resistance in human disease. Diabetes. 37:1595–1607. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pan K, Chlebowski RT, Mortimer JE, Gunter
MJ, Rohan T, Vitolins MZ, Adams-Campbell LL, Ho GYF, Cheng TD and
Nelson RA: Insulin resistance and breast cancer incidence and
mortality in postmenopausal women in the women's health initiative.
Cancer. 126:3638–3647. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qin G, Sun Z, Jin Y, Ren X, Zhang Z, Wang
S, Zhou G, Huang K, Zhao H and Jiang X: The association between the
triglyceride-glucose index and prognosis in postoperative renal
cell carcinoma patients: A retrospective cohort study. Front
Endocrinol (Lausanne). 15:13017032024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang AMY, Wellberg EA, Kopp JL and
Johnson JD: Hyperinsulinemia in obesity, inflammation, and cancer.
Diabetes Metab J. 45:285–311. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lien EC, Lyssiotis CA and Cantley LC:
Metabolic reprogramming by the PI3K-Akt-mTOR pathway in cancer.
Recent Results Cancer Res. 207:39–72. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Belfiore A, Frasca F, Pandini G, Sciacca L
and Vigneri R: Insulin receptor isoforms and insulin
receptor/insulin-like growth factor receptor hybrids in physiology
and disease. Endocr Rev. 30:586–623. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang AMY, Magrill J, de Winter TJJ, Hu X,
Skovsø S, Schaeffer DF, Kopp JL and Johnson JD: Endogenous
hyperinsulinemia contributes to pancreatic cancer development. Cell
Metab. 30:403–404. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stolzenberg-Solomon RZ, Graubard BI, Chari
S, Limburg P, Taylor PR, Virtamo J and Albanes D: Insulin, glucose,
insulin resistance, and pancreatic cancer in male smokers. JAMA.
294:2872–2878. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lv Z and Guo Y: Metformin and its benefits
for various diseases. Front Endocrinol (Lausanne). 11:1912020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gwinn DM, Shackelford DB, Egan DF,
Mihaylova MM, Mery A, Vasquez DS, Turk BE and Shaw RJ: AMPK
phosphorylation of raptor mediates a metabolic checkpoint. Mol
Cell. 30:214–226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Podhorecka M, Ibanez B and Dmoszyńska A:
Metformin-its potential anti-cancer and anti-aging effects. Postepy
Hig Med Dosw (Online). 71:170–175. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vallianou NG, Evangelopoulos A and Kazazis
C: Metformin and cancer. Rev Diabet Stud. 10:228–235. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Frasca F, Pandini G, Scalia P, Sciacca L,
Mineo R, Costantino A, Goldfine ID, Belfiore A and Vigneri R:
Insulin receptor isoform A, a newly recognized, high-affinity
insulin-like growth factor II receptor in fetal and cancer cells.
Mol Cell Biol. 19:3278–3288. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhong W, Wang X, Wang Y, Sun G, Zhang J
and Li Z: Obesity and endocrine-related cancer: The important role
of IGF-1. Front Endocrinol (Lausanne). 14:10932572023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang S, Wang N, Yu B, Cao M, Wang Y, Guo
Y, Zhang Y, Zhang P, Yu X, Wang S, et al: Circulating IGF-1
promotes prostate adenocarcinoma via FOXO3A/BIM signaling in a
double-transgenic mouse model. Oncogene. 38:6338–6353. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yakar S, Pennisi P, Zhao H, Zhang Y and
LeRoith D: Circulating IGF-1 and its role in cancer: Lessons from
the IGF-1 gene deletion (LID) mouse. Novartis Found Symp. 262:3–18.
265–268. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Malaguarnera R, Sacco A, Voci C, Pandini
G, Vigneri R and Belfiore A: Proinsulin binds with high affinity
the insulin receptor isoform A and predominantly activates the
mitogenic pathway. Endocrinology. 153:2152–2163. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ortega-Molina A and Serrano M: PTEN in
cancer, metabolism, and aging. Trends Endocrinol Metab. 24:184–189.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cheng H, Liu P, Zhang F, Xu E, Symonds L,
Ohlson CE, Bronson RT, Maira SM, Di Tomaso E, Li J, et al: A
genetic mouse model of invasive endometrial cancer driven by
concurrent loss of Pten and Lkb1 is highly responsive to mTOR
inhibition. Cancer Res. 74:15–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen J, Zhang XD and Proud C: Dissecting
the signaling pathways that mediate cancer in PTEN and LKB1
double-knockout mice. Sci Signal. 8:pe12015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang XL, Zhang L, Youker K, Zhang MX, Wang
J, LeMaire SA, Coselli JS and Shen YH: Free fatty acids inhibit
insulin signaling-stimulated endothelial nitric oxide synthase
activation through upregulating PTEN or inhibiting Akt kinase.
Diabetes. 55:2301–2310. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yu J, Shen J, Sun TT, Zhang X and Wong N:
Obesity, insulin resistance, NASH and hepatocellular carcinoma.
Semin Cancer Biol. 23:483–491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Leachman SA, Lucero OM, Sampson JE,
Cassidy P, Bruno W, Queirolo P and Ghiorzo P: Identification,
genetic testing, and management of hereditary melanoma. Cancer
Metastasis Rev. 36:77–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Olefsky JM and Glass CK: Macrophages,
inflammation, and insulin resistance. Annu Rev Physiol. 72:219–246.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kershaw EE and Flier JS: Adipose tissue as
an endocrine organ. J Clin Endocrinol Metab. 89:2548–2556. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Vozarova B, Weyer C, Hanson K, Tataranni
PA, Bogardus C and Pratley RE: Circulating interleukin-6 in
relation to adiposity, insulin action, and insulin secretion. Obes
Res. 9:414–417. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Grivennikov S, Karin E, Terzic J, Mucida
D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H,
Eckmann L and Karin M: IL-6 and Stat3 are required for survival of
intestinal epithelial cells and development of colitis-associated
cancer. Cancer Cell. 15:103–113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Gonullu G, Ersoy C, Ersoy A, Evrensel T,
Basturk B, Kurt E, Oral B, Gokgoz S and Manavoglu O: Relation
between insulin resistance and serum concentrations of IL-6 and
TNF-alpha in overweight or obese women with early stage breast
cancer. Cytokine. 31:264–269. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wu CT, Chen MF, Chen WC and Hsieh CC: The
role of IL-6 in the radiation response of prostate cancer. Radiat
Oncol. 8:1592013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bulló M, García-Lorda P, Peinado-Onsurbe
J, Hernández M, Del Castillo D, Argilés JM and Salas-Salvadó J:
TNFalpha expression of subcutaneous adipose tissue in obese and
morbid obese females: Relationship to adipocyte LPL activity and
leptin synthesis. Int J Obes Relat Metab Disord. 26:652–658. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Michalaki V, Syrigos K, Charles P and
Waxman J: Serum levels of IL-6 and TNF-alpha correlate with
clinicopathological features and patient survival in patients with
prostate cancer. Br J Cancer. 90:2312–2316. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cruceriu D, Baldasici O, Balacescu O and
Berindan-Neagoe I: The dual role of tumor necrosis factor-alpha
(TNF-α) in breast cancer: Molecular insights and therapeutic
approaches. Cell Oncol (Dordr). 43:1–18. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Pfalzer AC, Leung K, Crott JW, Kim SJ, Tai
AK, Parnell LD, Kamanu FK, Liu Z, Rogers G, Shea MK, et al:
Incremental elevations in TNFα and IL6 in the human colon and
procancerous changes in the mucosal transcriptome accompany
adiposity. Cancer Epidemiol Biomarkers Prev. 27:1416–1423. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zheng YJ, Ho W, Sanlorenzo M, Vujic I,
Daud A, Algazi A, Rappersberger K and Ortiz-Urda S: Melanoma risk
during immunomodulating treatment. Melanoma Res. 32:411–418. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Molinelli E, Ceccarelli G, Fantone S, Di
Mercurio E, Gambini D, Maurizi A, Perugini J, Tossetta G,
Brisigotti V, De Simoni E, et al: Melanoma and subcutaneous adipose
tissue: Role of peritumoral adipokines in disease characterization
and prognosis. Pigment Cell Melanoma Res. 36:423–430. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Sims EK, Carr ALJ, Oram RA, DiMeglio LA
and Evans-Molina C: 100 Years of insulin: Celebrating the past,
present and future of diabetes therapy. Nat Med. 27:1154–1164.
2021. View Article : Google Scholar : PubMed/NCBI
|
